Literature DB >> 22236431

Inherited defects causing hemophagocytic lymphohistiocytic syndrome.

Geneviève de Saint Basile1, Gaël Ménasché, Sylvain Latour.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) manifests as the uncontrolled activation of T lymphocytes and macrophages infiltrating multiple organs. Molecular studies of individuals with HLH have demonstrated in most of these conditions a critical role of granule-dependent cytotoxic activity in the regulation of lymphocyte homeostasis, and have allowed the characterization of key effectors regulating cytotoxic granule release. The cytolytic process may now be considered a multistep process, including cell activation; the polarization of cytotoxic granules toward the conjugated target cell; the tethering, priming, and fusion of the cytotoxic granules with the plasma membrane; and the release of their contents (perforin and granzymes) into the intercellular cleft, leading to target cell death. Cytolytic cells have a second effector function involving the production of cytokines, principally γ-interferon, which is secreted independently of the exocytosis cytotoxic granule pathway. An analysis of the mechanisms underlying HLH has identified γ-interferon as a key cytokine inducing uncontrolled macrophage activation, and thus represents a potential therapeutic target.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22236431     DOI: 10.1111/j.1749-6632.2011.06307.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness.

Authors:  Keith A Sikora; Ndate Fall; Sherry Thornton; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2012-11

Review 2.  Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Annu Rev Med       Date:  2014-11-05       Impact factor: 13.739

3.  11-Month-Old Infant With Periodic Fevers, Recurrent Liver Dysfunction, and Perforin Gene Polymorphism.

Authors:  Grant S Schulert; Kevin Bove; Richard McMasters; Kathleen Campbell; Nancy Leslie; Alexei A Grom
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

Review 4.  [Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Authors:  G Lachmann; P La Rosée; T Schenk; F M Brunkhorst; C Spies
Journal:  Anaesthesist       Date:  2016-10       Impact factor: 1.041

Review 5.  Macrophage activation syndrome and cytokine-directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

6.  Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency.

Authors:  Tayebeh Soheili; Amandine Durand; Fernando E Sepulveda; Julie Rivière; Chantal Lagresle-Peyrou; Hanem Sadek; Geneviève de Saint Basile; Samia Martin; Fulvio Mavilio; Marina Cavazzana; Isabelle André-Schmutz
Journal:  Blood Adv       Date:  2017-12-21

7.  Alternative UNC13D Promoter Encodes a Functional Munc13-4 Isoform Predominantly Expressed in Lymphocytes and Platelets.

Authors:  Donatella Galgano; Tayebeh Soheili; Matthias Voss; Lamberto Torralba-Raga; Bianca Tesi; Frank Cichocki; Isabelle Andre; Jens Rettig; Marina Cavazzana; Yenan Bryceson
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

8.  Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome.

Authors:  Guillaume Taieb; Elsa Kaphan; Claire Duflos; Christine Lebrun-Frénay; Valérie Rigau; Eric Thouvenot; Emeline Duhin-Gand; Romain Lefaucheur; Khe Hoang-Xuan; Sarah Coulette; Jean Christophe Ouallet; Nicolas Menjot de Champfleur; Christine Tranchant; Capucine Picard; Mathieu Fusaro; Fernando E Sepulveda; Pierre Labauge; Geneviève de Saint Basile
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-03-03

9.  Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report.

Authors:  Blessie Elizabeth Nelson; Angelina Hong; Mhair Dekmezian; Bagi Jana
Journal:  Case Rep Oncol       Date:  2021-07-05

10.  Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis.

Authors:  Sabine Mellor-Heineke; Joyce Villanueva; Michael B Jordan; Rebecca Marsh; Kejian Zhang; Jack J Bleesing; Alexandra H Filipovich; Kimberly A Risma
Journal:  Front Immunol       Date:  2013-03-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.